Categories · Health/Science
· Cessation
· Zyban
|
Jump to full article: Business Wire, 2003-10-28
Intro: Smokers who want to quit by taking the drug bupropion SR (marketed by GlaxoSmithKline as Zyban(R)) could see a substantial increase in their chances for quitting when the drug is taken in combination with a moderate level of behavioral modification counseling, according to a new study led by researchers at independent research institute SRI International.
The study shows that a combination of bupropion SR with minimal or moderate behavioral counseling results in a "quit rate" of 24% to 33% after one year, compared to a CDC-reported 5% quit rate for "self-quitters" after a three-month period (those who quit "cold turkey" without some form of assistance).
Jump to full article » |